trending Market Intelligence /marketintelligence/en/news-insights/trending/VvBZZ_Xj_mwT2cHGjYqv4w2 content esgSubNav
In This List

US FDA approves Anika's bone repair treatment

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


US FDA approves Anika's bone repair treatment

The U.S. Food and Drug Administration approved Anika Therapeutics, Inc.'s injectable bone repair treatment.

The U.S. regulator granted 510(k) clearance to the company's injectable hyaluronic acid-based bone void filler for filling bone voids or defects of the skeletal system.

The bone void filler is resorbed and replaced by the growth of new bone during the healing process.